{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:54:17Z","timestamp":1792090457093,"version":"4.4.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","license":[{"start":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T00:00:00Z","timestamp":1626652800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Chronic rejection, defined as chronic lung allograft dysfunction (CLAD), is the major factor limiting long-term survival after lung transplantation (LTx). A specific subgroup of CLAD is restrictive allograft syndrome (RAS). CLAD\u2019s pathogenesis is largely unknown, but previous findings suggest that it is associated with increased fibrosis in the transplanted lung. Cartilage oligomeric matrix protein (COMP) has been associated with multiple fibrotic conditions. The current study aimed to explore the relation between COMP serum levels and development of CLAD, and RAS in particular, in a retrospective cohort of LTx patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>This study included retrospective data from patients who underwent LTx during 2009\u20132011. Blood samples and spirometry data were obtained at follow-up visits 1, 3, 6, 9, and 12 mo after transplantation. Serum samples were analyzed for COMP. CLAD and RAS were defined according to the 2019 International Society for Heart and Lung Transplantation consensus document.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>Data from 38 patients (19 men and women, respectively) were collected. Twenty-three patients (60.5%) developed CLAD, of whom 6 (26.1 %) fulfilled the criteria for RAS. Patients who developed RAS had higher mean COMP levels between 1 and 3 mo after LTx than those who did not develop RAS (10.9 [3.9-17.5] U\/L vs 7.4 [3.9-10.8] U\/L, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2009=\u20090.008). RAS was also associated with shorter survival. We found no association between COMP levels and CLAD of other types than RAS.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>Serum level of COMP early after LTx seems to be associated with RAS development and might serve as a biomarker suitable for clinical use in the LTx setting.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/txd.0000000000001189","type":"journal-article","created":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T23:00:58Z","timestamp":1626735658000},"page":"e730","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["COMP: A Potential Early Biomarker of RAS After Lung Transplantation"],"prefix":"10.1097","volume":"7","author":[{"given":"Mirza","family":"Novo","sequence":"first","affiliation":[{"name":"Department of Internal Medicine\/Respiratory Medicine and Allergology, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Westin","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Sahlgrenska University Hospital, Gothenburg, Sweden."},{"name":"Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars-Magnus","family":"Andersson","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Sahlgrenska University Hospital, Gothenburg, Sweden."},{"name":"Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Jonsson Berdenius","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, Sahlgrenska University Hospital, Gothenburg, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rickard","family":"Nord\u00e9n","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden."},{"name":"Department of Clinical Microbiology, Sahlgrenska University Hospital, Gothenburg, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper M.","family":"Magnusson","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine\/Respiratory Medicine and Allergology, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,7,19]]},"reference":[{"key":"R1-20240805","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.healun.2019.08.001","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-sixth adult lung and heart-lung transplantation report-2019; Focus theme: donor and recipient size match.","volume":"38","author":"Chambers","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"R2-20240805","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.healun.2019.03.009","article-title":"Chronic lung allograft dysfunction: definition, diagnostic criteria, and approaches to treatment\u2014a consensus report from the pulmonary council of the ISHLT.","volume":"38","author":"Verleden","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"R3-20240805","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.healun.2019.03.008","article-title":"Chronic lung allograft dysfunction: definition and update of restrictive allograft syndrome\u2014a consensus report from the pulmonary council of the ISHLT.","volume":"38","author":"Glanville","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"R4-20240805","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1097\/TP.0000000000001215","article-title":"Chronic lung allograft dysfunction: a systematic review of mechanisms.","volume":"100","author":"Royer","year":"2016","journal-title":"Transplantation"},{"key":"R5-20240805","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1016\/j.transproceed.2013.06.013","article-title":"Biomarkers of pulmonary rejection.","volume":"45","author":"Berastegui","year":"2013","journal-title":"Transplant Proc"},{"key":"R6-20240805","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.matbio.2018.02.023","article-title":"Cartilage oligomeric matrix protein: COMPopathies and beyond.","volume":"71-72","author":"Posey","year":"2018","journal-title":"Matrix Biol"},{"key":"R7-20240805","doi-asserted-by":"crossref","first-page":"11347","DOI":"10.1074\/jbc.M608744200","article-title":"Cartilage oligomeric matrix protein associates with granulin-epithelin precursor (GEP) and potentiates GEP-stimulated chondrocyte proliferation.","volume":"282","author":"Xu","year":"2007","journal-title":"J Biol Chem"},{"key":"R8-20240805","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S1063-4584(03)00055-4","article-title":"Effect of cartilage oligomeric matrix protein on mesenchymal chondrogenesis in vitro.","volume":"11","author":"Kipnes","year":"2003","journal-title":"Osteoarthritis Cartilage"},{"key":"R9-20240805","doi-asserted-by":"crossref","first-page":"25294","DOI":"10.1074\/jbc.M403778200","article-title":"Interactions between the cartilage oligomeric matrix protein and matrilins. Implications for matrix assembly and the pathogenesis of chondrodysplasias.","volume":"279","author":"Mann","year":"2004","journal-title":"J Biol Chem"},{"key":"R10-20240805","doi-asserted-by":"crossref","first-page":"5585","DOI":"10.1038\/onc.2016.98","article-title":"Cartilage oligomeric matrix protein contributes to the development and metastasis of breast cancer.","volume":"35","author":"Englund","year":"2016","journal-title":"Oncogene"},{"key":"R11-20240805","doi-asserted-by":"crossref","first-page":"98298","DOI":"10.18632\/oncotarget.21176","article-title":"Cartilage oligomeric matrix protein promotes prostate cancer progression by enhancing invasion and disrupting intracellular calcium homeostasis.","volume":"8","author":"Englund","year":"2017","journal-title":"Oncotarget"},{"key":"R12-20240805","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s00432-018-2626-4","article-title":"Cartilage oligomeric matrix protein is a prognostic factor and biomarker of colon cancer and promotes cell proliferation by activating the Akt pathway.","volume":"144","author":"Liu","year":"2018","journal-title":"J Cancer Res Clin Oncol"},{"key":"R13-20240805","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.jhep.2017.03.043","article-title":"Cartilage oligomeric matrix protein associates with hepatic inflammation and fibrosis in hepatitis C virus infection.","volume":"67","author":"Andr\u00e9asson","year":"2017","journal-title":"J Hepatol"},{"key":"R14-20240805","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/1471-2474-14-229","article-title":"Early increase in serum-COMP is associated with joint damage progression over the first five years in patients with rheumatoid arthritis.","volume":"14","author":"Andersson","year":"2013","journal-title":"BMC Musculoskelet Disord"},{"key":"R15-20240805","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.3389\/fonc.2019.01141","article-title":"High levels of cartilage oligomeric matrix protein in the serum of breast cancer patients can serve as an independent prognostic marker.","volume":"9","author":"Papadakos","year":"2019","journal-title":"Front Oncol"},{"key":"R16-20240805","doi-asserted-by":"crossref","first-page":"e370","DOI":"10.1097\/TXD.0000000000000808","article-title":"Viral respiratory tract infection during the first postoperative year is a risk factor for chronic rejection after lung transplantation.","volume":"4","author":"Magnusson","year":"2018","journal-title":"Transplant Direct"},{"key":"R17-20240805","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1183\/09031936.93.02060561","article-title":"Report of the European Society of Pneumology Task Group.","volume":"2","year":"1989","journal-title":"Eur Respir J"},{"key":"R18-20240805","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1056\/NEJMra1300575","article-title":"Fibrosis\u2013a common pathway to organ injury and failure.","volume":"372","author":"Rockey","year":"2015","journal-title":"N Engl J Med"},{"key":"R19-20240805","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/modpathol.2017.180","article-title":"The histomorphological spectrum of restrictive chronic lung allograft dysfunction and implications for prognosis.","volume":"31","author":"von der Th\u00fcsen","year":"2018","journal-title":"Mod Pathol"},{"key":"R20-20240805","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/j.1600-6143.2009.02558.x","article-title":"Posttransplant bronchiolitis obliterans syndrome is associated with bronchial epithelial to mesenchymal transition.","volume":"9","author":"Hodge","year":"2009","journal-title":"Am J Transplant"},{"key":"R21-20240805","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1183\/09059180.00004413","article-title":"Tissue remodelling in chronic bronchial diseases: from the epithelial to mesenchymal phenotype.","volume":"23","author":"Pain","year":"2014","journal-title":"Eur Respir Rev"},{"key":"R22-20240805","doi-asserted-by":"crossref","first-page":"31166","DOI":"10.1074\/jbc.M705735200","article-title":"COMP acts as a catalyst in collagen fibrillogenesis.","volume":"282","author":"Hal\u00e1sz","year":"2007","journal-title":"J Biol Chem"},{"key":"R23-20240805","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.healun.2016.03.022","article-title":"Predictors of survival in restrictive chronic lung allograft dysfunction after lung transplantation.","volume":"35","author":"Verleden","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"R24-20240805","first-page":"521","article-title":"Tissue eosinophilia and eosinophil degranulation in syndromes associated with fibrosis.","volume":"140","author":"Noguchi","year":"1992","journal-title":"Am J Pathol"},{"key":"R25-20240805","doi-asserted-by":"crossref","first-page":"9660","DOI":"10.1073\/pnas.96.17.9660","article-title":"Human eosinophils regulate human lung- and skin-derived fibroblast properties in vitro: a role for transforming growth factor beta (TGF-beta).","volume":"96","author":"Levi-Schaffer","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R26-20240805","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1093\/hmg\/ddv122","article-title":"Antioxidant and anti-inflammatory agents mitigate pathology in a mouse model of pseudoachondroplasia.","volume":"24","author":"Posey","year":"2015","journal-title":"Hum Mol Genet"},{"key":"R27-20240805","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/j.ajpath.2011.06.034","article-title":"Identification and characterization of cartilage oligomeric matrix protein as a novel pathogenic factor in keloids.","volume":"179","author":"Inui","year":"2011","journal-title":"Am J Pathol"},{"key":"R28-20240805","doi-asserted-by":"crossref","first-page":"101224","DOI":"10.1016\/j.trim.2019.101224","article-title":"Collagen type-V is a danger signal associated with primary graft dysfunction in lung transplantation.","volume":"56","author":"Zaffiri","year":"2019","journal-title":"Transpl Immunol"},{"key":"R29-20240805","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1164\/rccm.200608-1079OC","article-title":"Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome.","volume":"175","author":"Daud","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"R30-20240805","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.healun.2007.07.018","article-title":"Primary graft dysfunction and long-term pulmonary function after lung transplantation.","volume":"26","author":"Whitson","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"R31-20240805","doi-asserted-by":"crossref","first-page":"L401","DOI":"10.1152\/ajplung.00080.2012","article-title":"IL-17 induces type V collagen overexpression and EMT via TGF-\u03b2-dependent pathways in obliterative bronchiolitis.","volume":"304","author":"Vittal","year":"2013","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"R32-20240805","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3389\/fmed.2017.00109","article-title":"Development of a multivariate prediction model for early-onset bronchiolitis obliterans syndrome and restrictive allograft syndrome in lung transplantation.","volume":"4","author":"Koutsokera","year":"2017","journal-title":"Front Med (Lausanne)"},{"key":"R33-20240805","doi-asserted-by":"crossref","first-page":"e83120","DOI":"10.1371\/journal.pone.0083120","article-title":"Cartilage oligomeric matrix protein in idiopathic pulmonary fibrosis.","volume":"8","author":"Vuga","year":"2013","journal-title":"PLoS One"},{"key":"R34-20240805","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.joca.2004.09.007","article-title":"Serum concentration of cartilage oligomeric matrix protein (COMP) is sensitive to physiological cyclic loading in healthy adults.","volume":"13","author":"M\u00fcndermann","year":"2005","journal-title":"Osteoarthritis Cartilage"}],"updated-by":[{"DOI":"10.1097\/txd.0000000000001302","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T00:00:00Z","timestamp":1644451200000}}],"container-title":["Transplantation Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001189","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T05:08:21Z","timestamp":1722834501000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,19]]},"references-count":34,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/txd.0000000000001189","relation":{"correction":[{"id-type":"doi","id":"10.1097\/TXD.0000000000001302","asserted-by":"object"}]},"ISSN":["2373-8731"],"issn-type":[{"value":"2373-8731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,19]]}}}